Titelia

Holdings of GREAT POINT PARTNERS LLC

31 declared positions · as of Mar 31, 2026

Original filing · Ten largest lines: 60.8 % of the equity sleeve

Sector breakdown

  • Unattributed 100.0 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • US 98.3 %
  • GB 1.7 %

Shares computed on the equity sleeve.

CountryLinesValueShare
US30313.2M $98.31 %
GB15.4M $1.69 %

Positions

CompanySharesValueWeight
Apogee Therapeutics Inc 374,00031.5M $
Vor BioPharma Inc 1,750,00031.2M $
Amylyx Pharmaceuticals Inc 1,750,00024.3M $
Nektar Therapeutics 316,45322.8M $
Alumis Inc 856,06118.9M $
Annexon Inc 2,500,00013.9M $
KalVista Pharmaceuticals Inc 675,00013.6M $
Immunovant Inc 545,62513.6M $
JADE BIOSCIENCES INC 964,46213.6M $
Contineum Therapeutics Inc 800,19810.5M $
ZENAS BIOPHARMA INC 524,06610.2M $
Neurogene Inc 500,00010.1M $
Climb Bio Inc 1,334,1309.1M $
Oruka Therapeutics Inc 183,3309M $
Vera Therapeutics Inc 199,3488M $
Evommune Inc 325,0007.5M $
LB Pharmaceuticals Inc 300,0007.4M $
Compass Therapeutics Inc 1,350,0007.1M $
SCYNEXIS INC 7,554,3476.9M $
Palisade Bio Inc 3,405,7576M $
Context Therapeutics Inc 2,238,4965.9M $
Relmada Therapeutics Inc 842,1065.9M $
Silence Therapeutics PLC 1,020,4895.4M $
Unicycive Therapeutics Inc 796,5585.2M $
Tenax Therapeutics Inc 327,3075.2M $
Cullinan Therapeutics Inc 300,0004.3M $
Immix Biopharma Inc 350,0003.2M $
Rezolute Inc 951,8092.9M $
Humacyte Inc 3,750,0002.3M $
AVALO THERAPEUTICS INC 124,6661.9M $
Opus Genetics Inc 324,3401.5M $